Oculus secures U.S. patent for skin ulcer technology

12/28/2012 | MedCityNews.com

Oculus Innovative Sciences has received a U.S. patent for its Microcyn Technology to be used in treating patients with skin ulcers. The technology is administered to skin ulcers either by irrigation, soaking and washing, or by applying a wound dressing that has been soaked with the technology.

View Full Article in:

MedCityNews.com

Published in Briefs:

SmartBrief Job Listings for Health Care